Stevens Capital Management LP Sells 4,472 Shares of The Clorox Company $CLX

Stevens Capital Management LP decreased its stake in The Clorox Company (NYSE:CLX) by 67.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,192 shares of the company’s stock after selling 4,472 shares during the period. Stevens Capital Management LP’s holdings in Clorox were worth $270,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares during the last quarter. Woodline Partners LP grew its stake in shares of Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Clorox during the second quarter worth $216,000. Stephens Inc. AR raised its position in Clorox by 32.4% during the second quarter. Stephens Inc. AR now owns 3,778 shares of the company’s stock worth $454,000 after acquiring an additional 924 shares in the last quarter. Finally, Brookstone Capital Management raised its position in Clorox by 6.4% during the second quarter. Brookstone Capital Management now owns 6,308 shares of the company’s stock worth $757,000 after acquiring an additional 381 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Clorox stock opened at $123.51 on Friday. The company has a market capitalization of $14.93 billion, a price-to-earnings ratio of 20.18, a PEG ratio of 0.61 and a beta of 0.59. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The Clorox Company has a 12 month low of $96.66 and a 12 month high of $159.04. The stock’s 50 day moving average is $109.75 and its 200-day moving average is $113.59.

Clorox (NYSE:CLX) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the firm earned $1.55 earnings per share. The business’s revenue for the quarter was down .8% compared to the same quarter last year. Equities research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Zacks raised its FY2028 EPS view to $7.23 and upgraded select quarterly/annual estimates (including Q1 2028 to $1.37 and Q4 2026/2027 increases), signaling modestly better forward earnings visibility that can support the stock.
• Positive Sentiment: Clorox published a consumer research report “Home Care Redefined” that underscores evolving demand for wellness- and convenience-oriented home-care products — a strategic tailwind for branded consumer staples. Home Care Redefined
• Neutral Sentiment: Management presented at the Consumer Analyst Group of New York (CAGNY) conference; slides and prepared remarks provide more detail on strategy, cost actions and growth initiatives — useful for longer-term positioning but not an immediate earnings surprise. CAGNY Slides Transcript
• Negative Sentiment: Zacks trimmed multiple near-term quarterly EPS forecasts (several Q2–Q3 2026/2027 cuts and FY2027 lowered to $6.74), reflecting caution about near-term volume/mix or cost pressure — a potential headwind for sentiment and short-term guidance expectations.
• Negative Sentiment: Wells Fargo issued a “Hold” on CLX (reported as “receives a Hold”), which keeps sell-side sentiment neutral-to-cautious and may limit near-term upside from upgrades. Wells Fargo Hold

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on CLX shares. Jefferies Financial Group lowered their price objective on shares of Clorox from $152.00 to $151.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Barclays reiterated an “underweight” rating and set a $109.00 price target on shares of Clorox in a report on Friday, January 16th. Weiss Ratings lowered Clorox from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, February 4th. Morgan Stanley raised their price objective on Clorox from $125.00 to $136.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Finally, Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Reduce” and an average price target of $118.73.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.